|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2887 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K2039/545 | (2013.01) |
| (11) | Patento numeris | 3697818 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18804720.3 |
| Europos patento paraiškos padavimo data | 2018-10-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-08-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-11-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2018/038924 |
| Data | 2018-10-19 |
| (87) | Numeris | WO 2019/017499 |
| Data | 2019-01-24 |
| (30) | Numeris | Data | Šalis |
| 201762574297 P | 2017-10-19 | US |
| (72) |
WENGER, Michael , CH
MOBASHER, Mehrdad , US
LIN, Chin-Yu , US
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | TREATMENT OF CD20-POSITIVE B-CELL LYMPHOMA WITH OBINUTUZUMAB |
| TREATMENT OF CD20-POSITIVE B-CELL LYMPHOMA WITH OBINUTUZUMAB |